Rialto Wealth Management, LLC Pds Biotechnology Corp Transaction History
Rialto Wealth Management, LLC
- $342 Million
- Q2 2025
A detailed history of Rialto Wealth Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Rialto Wealth Management, LLC holds 400 shares of PDSB stock, worth $388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$388% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
58Shares Held
7.69MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.17 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.89 Million0.0% of portfolio
-
Ubs Group Ag543KShares$526,7300.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$472,3570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$405,3950.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $27.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...